Shukun Technology, a Beijing-based artificial intelligence (AI) medical technology firm, today announced that it has raised a RMB200 million (US$29.52 million) series B financing round led by China Creation Ventures, a venture capital firm focusing on TMT sector in China.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
